Status:
ACTIVE_NOT_RECRUITING
Clinical Study on Monitoring the Plasma Concentration of Ceftazidime-Avibactam in Critically Ill Patients
Lead Sponsor:
First Affiliated Hospital of Zhejiang University
Conditions:
Severe Sepsis
Eligibility:
All Genders
18+ years
Brief Summary
A observational study is conducting at the First Affiliated Hospital of the Medical College of Zhejiang University from June 1, 2021 to January 1, 2024. Patients with severe sepsis and treatment with ...
Detailed Description
The investigators will collect the blood samples at different time points: 0 hour, 2 hours, 4 hours, 6 hours, and 8 hours after the first time and the steady state concentration(more than 4 times drug...
Eligibility Criteria
Inclusion
- Patients with severe sepsis and treated with ceftazidime avibactam
- Age ≥ 18 years
- The patient or authorized persons agree and sign the informed consent
- The patient's hemoglobin is greater than 70g/l during blood collection
Exclusion
- The expected length of ICU stay less than 48 hours,
- Pregnant woman,
- The blood sample is hemolysis.
Key Trial Info
Start Date :
June 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 31 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05413343
Start Date
June 1 2021
End Date
October 31 2025
Last Update
August 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The First Affiliated Hospital,College of Medicine,Zhejiang University
Hangzhou, Zhejiang, China, 310000